Medicamen Organics Limited — Board Meeting, 08-01-2025: Outcome of Board Meeting

The Board has approved a fundraising initiative of ₹3 Cr through the issuance of up to 4,65,910 Convertible Warrants at ₹64.39 each, granting rights to convert these into equity shares at a premium. This decision will seek members' consent via a postal ballot, with the draft notice and an appointed scrutinizer also approved. Post-issue, the promoter shareholding will increase from 59.69% to 61.24%. This strategic move is aimed at strengthening the company's capital base.